Arctic Vision

About:

Arctic Vision is focused on the development and commercialization of innovative ophthalmology therapies.

Website: http://www.arcticvision.com/

Top Investors: Tencent, Loyal Valley Capital, Morningside Group, Octagon Capital Advisors, Adrian Cheng

Description:

Arctic Vision is a China-based clinical-stage specialty ophthalmology company with a leading portfolio of breakthrough technologies. The Company's vision is to address ophthalmology's unmet needs through innovative therapies in China, Asia, and globally. Arctic Vision is established by top-tier life sciences investors and led by an elite team of ophthalmic industry veterans with substantial and compelling China and global experiences in R&D and commercialization of eye care products.

Total Funding Amount:

$132M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Shanghai, Shanghai, China

Founded Date:

2019-01-01

Contact Email:

info(AT)arcticvision.com

Founders:

Eddy Wu

Number of Employees:

101-250

Last Funding Date:

2021-03-09

IPO Status:

Private

Industries:

© 2025 bioDAO.ai